Caplight Directory>Companies>Ophthalytics Inc-preview>360intelligentdiagnostics


Ophthalytics Inc

Ophthalytics Inc

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://360intelligentdiagnostics.com/

Last Round

Accelerator

Oct 24, 2024

Momentum Score

25 /100

Company Overview

Ophthalytics Inc is a healthcare technology company that provides an AI-based diagnostic platform for the early detection and diagnosis of ophthalmic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

diabetic retinopathy screeningAI medical diagnosismedical imaging AIophthalmology AIretinal image analysispoint-of-care diagnosticscomputer visionSaaS platformhealth equity technologypay-per-exam modelusage-based billingcamera-agnosticHIPAA compliantclinical trial supportFDA clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ophthalytics Inc Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ophthalytics Inc Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 24, 2024
AcceleratorJul 15, 2024
AcceleratorJul 12, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Awais Bajwa

Founder & CEO

Founding Team

Ophthalytics Inc Investors

Notable investors and investment history

InvestorRounds
Creative Destruction LabAccelerator
MATTERAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Grew 30% QoQ, from 10 to 13 employees.

  • Feb 25, 2026

    Grew 50% QoQ from 8 to 12 employees.

View all signals

Ophthalytics Inc Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ophthalytics Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ophthalytics Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range13
Year Founded2020
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.